Filter Results:
(152)
Show Results For
- All HBS Web
(1,283)
- People (5)
- News (152)
- Research (918)
- Events (6)
- Multimedia (12)
- Faculty Publications (752)
Show Results For
- All HBS Web
(1,283)
- People (5)
- News (152)
- Research (918)
- Events (6)
- Multimedia (12)
- Faculty Publications (752)
Page 1 of 152
Results →
Sort by
- 06 Sep 2022
- News
Our September Issue: Nurses, Care Delivery, Pharmaceuticals & More
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
In 2008, private investors and the National Institutes of Health plowed more than $100 billion into pharmaceutical research. And yet, “We’re not seeing the new diagnostics, treatments, preventative approaches, and cures that we might have... View Details
- 28 Feb 2020
- News
Filling the White Space
At Able Partners, Amanda Eilian (MBA 2006) and Lisa Blau (MBA 2003) have focused primarily on women-led wellness companies, including businesses such as Goop, Moon Juice, and Daily Harvest. Now the New York–based investment firm has turned its attention to Compass... View Details
- 01 Mar 2007
- News
Daniel Vasella
portfolio of product lines, setting Novartis apart from its global competitors. Although initially regarded by critics as too inexperienced to lead a multinational pharmaceutical company, Vasella has triumphed. Three years ago he was... View Details
- 29 Oct 2015
- News
Options to Promote Competitive Generics Markets in the United States
- 28 Sep 2015
- News
Healthcare Inequality
- 20 Mar 2015
- News
Big Pharma Needs to Get Busy in the Lab
- 15 Sep 2016
- News
Price of pharma innovation: Pro
- 01 Oct 2011
- News
Resistance Is Futile
- 09 Nov 2011
- News
Resistance Is Futile
- 26 Apr 2010
- News
Pharma's Future Depends on These Three Trends
- 04 Nov 2016
- News
New war on drugs: Pharma becoming 'uninvestable'?
- 21 Mar 2016
- News
Valeant Analysts Aren't Alone in Thinking 'Sell' Is a Dirty Word
- 22 Feb 2011
- News